Nivolumab and Ipilimumab: nivolumab: Injection concentrate for I.V. infusion 40 mg in 4 mL, Injection concentrate for I.V. infusion 100 mg in 10 mL; ipilimumab: Injection concentrate for I.V. infusion 50 mg in 10 mL, Injection concentrate for I.V. infusion 200 mg in 40 mL; Opdivo® Yervoy®

Page last updated: 6 March 2020

• Public Summary Document (PSD) November 2019 PBAC Meeting - (PDF 706KB)
• Public Summary Document (PSD) November 2019 PBAC Meeting - (Word 181KB)